Hydroxycarbamide for sickle-cell anaemia in infancy.

Weatherall, D J

Weatherall, D J.

Affiliation

Weatherall DJ; Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK. liz.rose@imm.ox.ac.uk

Lancet ; 377(9778): 1628-30, 2011 May 14.

Article in En | MEDLINE | ID: mdl-21571132

Subject(s)

Anemia, Sickle Cell/drug therapy; Antisickling Agents/therapeutic use; Hydroxyurea/therapeutic use; Anemia, Sickle Cell/blood; Anemia, Sickle Cell/physiopathology; Antisickling Agents/adverse effects; Fetal Hemoglobin/metabolism; Humans; Hydroxyurea/adverse effects; Infant; Neutropenia/chemically induced; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxyurea / Anemia, Sickle Cell / Antisickling Agents Limits: Humans / Infant Language: En Journal: Lancet Year: 2011 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google